Tesla (NASDAQ:TSLA) Maintained “overweight” rating With a $275.00 Price Target by Barclays
Tesla (NASDAQ:TSLA) Maintained “overweight” rating With a $275.00/Share Price Target by Barclays.
Tesla (NASDAQ:TSLA) Maintained “overweight” rating With a $275.00/Share Price Target by Barclays.
Benchmark analyst Michael Ward reiterates Ford Motor (NYSE:F) with a Buy and maintains $19 price target.
Benchmark reiterates Ford Motor (NYSE:F) with a Buy and maintains $19 price target Read Post »
Barclays Adjusts Price Target on 3M Company (NYSE:MMM) to $105 From $122, Keeps Underweight Rating
Barclays Adjusts Price Target on 3M Company (NYSE:MMM) to $105 From $122 Read Post »
Guggenheim analyst Michael Morris upgrades Warner Music Gr (NASDAQ:WMG) from Neutral to Buy and raises the price target from $35 to $36.
Guggenheim raised Warner Music (NASDAQ:WMG) price target from $35 to $36 Read Post »
Evercore ISI Adjusts Price Target on Etsy to $140 From $153, Maintains Outperform Rating
Etsy (NASDAQ:ETSY) Given New $140.00 Price Target at Evercore ISI Read Post »
Wells Fargo & Company Trims Centene (NYSE:CNC) Target Price to $71.00 from $79.00 with an equalweight rating
Wells Fargo & Company Trims Centene (NYSE:CNC) Target Price to $71.00 Read Post »
Oppenheimer analyst C. Kotowski now expects that Morgan Stanley (NYSE:MS) will post earnings of $1.63 per share for the quarter, down from their prior estimate of $1.83. Oppenheimer has a “Outperform” rating and a $95.00 price target on the stock.
Oppenheimer analyst C. Kotowski now expects that JPMorgan Chase (NYSE:JPM) to Post Q1 2023 Earnings of $3.14 Per Share for the quarter, down from their prior forecast of $3.20. Oppenheimer currently has a “Outperform” rating and a $157.00 target price on the stock.
Goldman Sachs (NYSE:GS) to Post Q1 2023 Earnings of $9.38 Per Share, Oppenheimer Forecasts
Morgan Stanley analyst Carlos De Alba maintains Nucor (NYSE:NUE) with a Equal-Weight and raises the price target from $122 to $131.
Morgan Stanley Maintains Equal-Weight on Nucor (NYSE:NUE), Raises Price Target to $131 Read Post »
Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $325 price target.
Needham Reiterates Buy on Biogen (NASDAQ:BIIB) , Maintains $325 Price Target Read Post »
Bernstein analyst Mark Moerdler maintains SAP (NYSE:SAP) with a Outperform and raises the price target from $144 to $154.
Bernstein Adjusts SAP Price Target to $154 From $144, Maintains Outperform Rating Read Post »